Navigation Links
Drugs Used In Osteoporosis Can Help Prevent Periodontal Bone Loss

The graduate, Leena Bahl Palomo, D.D.S and M.S.D, tracked 60 menopausal women who had visited University Hospitals of Cleveland for osteoporosis and who had also visited the Case dental clinics. Nabil Bissada, chair and professor // of Case's department of Periodontology; and James Liu, chair of the department of obstetrics and gynecology of University Hospitals of Cleveland collaborated with Ms Palomo in the study. In the study, Palomo monitored women who were on daily or weekly bisphosphonate for at least three months. This therapy regimen is given to regenerate bone mass. These women were aged between 51 and 79 and participants did not smoke or use tobacco or estrogen products. Neither did they have any chronic conditions like diabetes which raises the risk of periodontal disease. However, the participants of the risedronate group did acknowledge that they took a higher level of vitamins and calcium supplements. All women in the study were assessed for the presence of any amount of inflammation, depth of the periodontal pocket, recession of the gums, mobility of the teeth and the presence of plaque. All these factors are standard parameters for gum disease as established by the American Academy of Periodontology. It was found that the risedronate therapy group had better periodontal status in five of the six above mentioned conditions. Gum recession did not vary greatly in either group.

'We found a significant difference between the women who used the medications from the women who did not,' said Palomo. 'In the same way that the bisphosphonate is helping to prevent hip and vertebral fractures, the medications also prevent the loss of bone in the jaws--the bones which support the teeth. With a close link established between osteoporosis and periodontal disease, similar treatment and management of the disease might minimize tooth loss and the destruction of the alveolar (jaw) bone.'

The details of the study appear in the current issue of th e Menopause journal.

Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University


Medindia on osteoporosis:

Osteoporosis is often known as "the silent thief" because bone loss occurs without symptoms and the progressive loss and thinning of bone tissue happens over many years.

Medindia links:

www.medindia.net/patients/
patientinfo/osteoporosis.asp


www.medindia.net/Patients/
PatientInfo/lifeosteoporosis_about.htm


www.medindia.net/healthday/
worldosteoporosisday.asp

'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: